Imaging inflammation in abdominal aortic aneurysm using a PET tracer
Official title: Molecular Imaging of the Underlying Mechanism of Vessel Wall Inflammation Using Positron Emission Tomography (PET/CT)
Run by University of Pennsylvania · NCT07548099 · Data updated 2026-11-12
Researchers are testing whether a new PET tracer, 64Cu-DOTA-ECL1i, can image inflammation in an abdominal aortic aneurysm.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | April 30, 2026 |
| Main results expected | April 30, 2028 |
| Study ends | April 30, 2029 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT07548099 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with an established abdominal aortic aneurysm or age-matched controls without AAA.
✕Probably not a fit
Patients with conditions preventing PET imaging or with low GFR, pregnancy, allergy to iodinated contrast, or other exclusion criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study uses a novel radiotracer with PET/CT to visualize inflammation in the aorta of adults with abdominal aortic aneurysm. Participants will undergo baseline PET/CT with 64Cu-DOTA-ECL1i and a follow-up scan about 6-8 weeks later to assess consistency of tracer uptake and the effect of clinical changes on imaging. The goal is to understand whether this molecular imaging approach can reflect inflammatory activity linked to aneurysm biology. The study is conducted at Penn Medicine under institutional guidelines and is not designed as a therapeutic intervention.
Why it matters
Potential benefit: If successful, the imaging approach could help identify inflammatory activity in AAAs and improve understanding of aneurysm biology.
How similar studies have gone: Previous research suggests molecular imaging can visualize vascular inflammation, but this specific tracer in AAA is exploratory and not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Participants will be at least 18 years of age 2. Have an established diagnosis of abdominal aortic aneurysm based on standard clinical criteria or are an age matched control with absence of known AAA. 3. Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this study in accordance with institutional and federal guidelines prior to study-specific procedures. Exclusion Criteria: 1. Females who are pregnant or breast feeding at the time of the PET/CT scan will not be eligible for this study; a urine pregnancy test will be performed in women of child-bearing potential before the injection of radiotracer. 2. Inability to tolerate imaging procedures in the opinion of an investigator or treating physician 3. Patients with chronic renal disease whose GFR is less than 40 mL/min/1.73m² at the time of enrollment. 4. Documented allergy to iodinated contrast 5. Any current medical condition, illness, or disorder as assessed by medical record review and/or self-reported that is considered by a physician investigator to be a condition that could compromise participant safety or successful participation in the study 6. Less than 6 months life expectancy as deemed by the treating physician at the time of initial enrollment.
Where it's running
-
Penn Medicine; Perelman School of Medicine
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Scott M Damrauer, MD — Penn Medicine Division of Vascular Surgery
- Study coordinator: Erin Schubert
- Email: erin.schubert@pennmedicine.upenn.edu
- Phone: 215-573-6569
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cardiovascular Rehabilitation After Abdominal Aortic Aneurysm Repair
This study tests whether a structured cardiovascular rehabilitation program after abdominal aortic aneurysm repair leads to better fitness and quality of life than standard postoperative care.
-
Poland–Italy Aortic Bridge Registry: PERCUTEK Tycheseal for Abdominal Aortic Aneurysm
This registry will see how well the PERCUTEK Tycheseal stent-graft works and how safe it is for adults having endovascular repair of abdominal aortic aneurysms.
-
PET scan to image MMP activity in abdominal aortic aneurysm
We will test whether a new PET tracer ([64Cu]-RYM2) can safely image MMP activity in people with abdominal aortic aneurysm and in healthy volunteers.
-
CTA registry for abdominal aortic aneurysm measurements
This registry will collect CT angiography scans from people with abdominal aortic aneurysms to see if CTA measurements reliably describe aneurysm size and features.
-
Cygnum aneurysm sac lining used with EVAR for abdominal aortic aneurysm
This trial will test whether adding the Cygnum sac lining to standard EVAR is safe and helps prevent type II endoleaks in people with abdominal aortic aneurysms.
-
Evaluation of a 3D-Printed Stent-Graft for Aortic Aneurysms
This study is testing a new 3D-printed stent-graft to see if it works better and is safer than standard devices for treating complex abdominal aortic aneurysms in about 100 patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.